In this solo episode, Dr. Marianne explores how the growing popularity of GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro is reshaping the body diversity movement. As weight loss drugs become more widely used and celebrated, messages of fat liberation and weight-inclusive care are being challenged in new and complex ways.

Dr. Marianne discusses the cultural effects of GLP-1s, the pressure many people feel to conform to changing body ideals, and what this means for fat humans, eating disorder recovery, and those committed to body autonomy. This episode offers a compassionate and honest look at the grief, confusion, and questions arising in this new era.

If you're navigating the intersection of weight stigma, eating disorders, and the rise of GLP-1 medications, this conversation will help you feel grounded, supported, and less alone.

🔗 Learn more about the Binge Eating Recovery Membership: drmariannemiller.com

CHECK OUT OTHER EPISODES ON BODY DIVERSITY & BODY LIBERATION!

INTERESTED IN HANGING OUT MORE IN DR. MARIANNE-LAND?